Mometasone furoate

Details

Files

Generic Name:

Mometasone furoate

Project Status:

Complete

Therapeutic Area:

Asthma

Manufacturer:

Merck Canada Inc.

Call for patient/clinician input open:

November 17, 2011

Brand Name:

ASMANEX

Project Line:

Reimbursement Review

Project Number:

SR0258-000

Call for patient/clinician input closed:

November 21, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Asthma, (Bronchial) Prophylactic management of steroid responsive

Recommendation Type:

List

Final Recommendation:

May 16, 2012

Last Updated : November 10, 2011